Ad
related to: replacement drug for repatha injectiongoodrx.com has been visited by 100K+ users in the past month
"About 50% of US physicians advise patients consult GoodRx." - Fortune
- Free Discount Card
Get a Free Discount Card Today and
Start Saving up to 80% Off Your Rx
- Do I Need Insurance?
No! Compare Our Prices to Your
Insurance & Get the Biggest Savings
- Phone Support Available
Our dedicated customer support team
is here to help answer questions.
- How GoodRx® Works
Get Rx Coupons, Save Up to 80%
No Commitment & No Fees
- Free Discount Card
Search results
Results from the WOW.Com Content Network
Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) .
Starting in 2025, there is a cap of $2,000 on the amount people will pay OOP for prescription drugs. Repatha’s website states that with self-purchased or employer-based insurance, 82% of ...
Side effects that occurred in more than 2% of people treated with alirocumab in clinical trials and that occurred more frequently than with placebo, included nose and throat irritation, injection site reactions and bruising, flu-like symptoms, urinary tract infection, diarrhea, bronchitis and cough, and muscle pain, soreness, and spasms.
Depot injections can be created by modifying the drug molecule itself, as in the case of prodrugs, or by modifying the way it is administered, as in the case of oil/lipid suspensions. Depot injections can have a duration of action of one month or greater and are available for many types of drugs, including antipsychotics and hormones .
CRISPR Therapeutics (NASDAQ: CRSP) and Moderna (NASDAQ: MRNA) have much in common. They're both innovative biotechs working in relatively newer niches of this booming industry. However, they've ...
For premium support please call: 800-290-4726 more ways to reach us
The first list was published in 1977 and included 208 medications. [8] [2] [9] The WHO updates the list every two years. [10] There are 306 medications in the 14th list in 2005, [11] 410 in the 19th list in 2015, [10] 433 in the 20th list in 2017, [12] [13] 460 in the 21st list in 2019, [14] [15] [16] and 479 in the 22nd list in 2021.
Makers of the new Alzheimer's drug, Leqembi, say their twice-monthly infusion could be available in injection form at pharmacies by early 2025 — if all goes well in ongoing trials and the ...